{"id":"W4415940413","doi":"10.1016/j.annonc.2025.08.3697","title":"3083P JAVELIN bladder medley phase II trial of avelumab + sacituzumab govitecan (Ave + SG) vs avelumab monotherapy (Ave mono) as first-line (1L) maintenance treatment for advanced urothelial carcinoma (aUC): Subgroup analyses based on metastatic sites","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Merck","keywords":"Javelin; Avelumab; Interim analysis; Bladder cancer; Chemotherapy; Urothelial carcinoma; Subgroup analysis; Merkel cell carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009811481,0.0006851109,0.001708823,0.0002350222,0.0002304331,0.0009733031,0.0005175413,0.0006435614,0.005409075],"category_scores_gemma":[0.0008151414,0.000344301,0.00197362,0.0003212414,0.0003417326,0.0005042002,0.0002935306,0.001857364,0.0006347199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005862156,"about_ca_system_score_gemma":0.0007379424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023309,"about_ca_topic_score_gemma":0.004382193,"domain_scores_codex":[0.9996386,0.0002084133,0.00001590112,0.00005826392,0.00002387926,0.00005501859],"domain_scores_gemma":[0.9996873,0.00008638429,0.00007182953,0.00003370067,0.00002002437,0.000100747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9072607,0.002926279,0.005087487,0.0009830447,0.006222012,0.00006751093,0.00008206059,0.001392812,0.008084582,0.0003633322,0.004312014,0.06321815],"study_design_scores_gemma":[0.8492901,0.1032145,0.0269542,0.000198198,0.007040415,0.0001957556,0.0001207419,0.002300186,0.001829109,0.0007938381,0.008005978,0.00005693495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822931,0.009462109,0.0004977897,0.001144977,0.0004259411,0.0006477683,0.002498098,0.00008610666,0.002944254],"genre_scores_gemma":[0.9864247,0.003003274,0.0008613316,0.0008253081,0.000168123,0.0005010664,0.002402048,0.00002832127,0.005785878],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005409075,"threshold_uncertainty_score":0.01809514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1212997898556165,"score_gpt":0.4482988970148013,"score_spread":0.3269991071591848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}